U.S. District Judge Denise Cote also ordered Friday that "Pharma Bro" Shkreli pay a $64.4 million fine.
Califf said that his reasoning for returning to the FDA is public service, saying that he is "a 70-year-old person with nothing to gain."
Vyera Pharmaceuticals LLC and its parent company will pay $40 million over a 10-year period after increasing the price of Daraprim from $17.50 to $750 per pill.
The FDA said with the drug, children with the most common form of dwarfism have "a treatment option that targets the underlying cause of their short stature."
Attorney General Bob Ferguson has taken McKesson Corp., Cardinal Health Inc. and Amerisource Bergen Corp. to court.
The company that will focus on brands like Neutrogena, Aveeno, Band-Aid and Listerine, has yet to be named.
Over 3,300 lawsuits have been filed across the U.S. over an opioid epidemic that led to nearly 500,000 overdose deaths between 1999 and 2019.
The two counties are suing retail pharmacies for their involvement in the opioid crisis, and Rite-Aid previously settled in August for $1.5 million for one county.
Late-stage human trials showed that AstraZeneca's antibody drug reduced the risk of developing symptomatic COVID-19 by 77 percent.
The administration is hoping to address competition issues by curbing price hikes on name-brand drugs and limiting the power of patent holders.
There are telltale signs users can look for to identify if their meds are the real thing.
As a lifelong Democrat, I'm proud to see Congress on the verge of passing this historic legislation. I understand the need to pay for these critical investments. But there are other ways to fund much needed reforms—ways that don't make drugs even more expensive.
The medical community's safety concerns end when it comes to pills that cause abortion.
Congress should enact regulations to loosen the grip the pharmaceutical industry has on America's doctors.
Organic and non-GMO ingredients should be used whenever possible, and should be sourced responsibly and ethically with stringent policies in place.
"If we were trying to bring in drugs from some country that wasn't reputable, I wouldn't want to go down that road either, but Canada has the same drugs," Florida Governor Ron DeSantis said.
People in the businesses of health and wellness have every reason to launch new and bigger efforts to reach consumers across every platform available, providing engaging, credible content that stands out amid the noise.
Fauci had previously called preliminary results from Johnson & Johnson's Phase III trial "really encouraging."
Johnson & Johnson say their vaccine is 66 percent effective overall in preventing moderate to severe COVID-19.
The agency said data collected from the vaccination rollout in Europe is consistent with the known safety profile of the vaccine and no new side effects have been identified.
To date, the Food and Drug Administration has authorized two monoclonal antibody therapies for emergency use in the treatment of COVID-19.
Over the summer, the Department of Health and Human Services issued a rule allowing health insurers to implement "accumulator adjustment programs," which allow insurers to effectively double charge customers for drugs.
Regeneron Pharmaceuticals, the creator of the antibody cocktail given to President Trump as part of his COVID-19 treatment, says the company also reached out to former Vice President Joe Biden to offer him the treatment as well.
Rep. Rashida Tlaib (D-Mich.) accused the CEO of drug company Teva of pretending to "look like you give a shit about sick people" while making ever-increasing profits during House testimony on Wednesday.
The pharmaceutical industry has criticized President Donald Trump's new executive order aimed at lowering drug prices.
Pharmaceutical giant Sinophram has priced their vaccine candidate at $145, the most expensive vaccine quote yet.
President Donald Trump is expected to sign an executive order while visiting Ohio, that would require the federal government to purchase certain drugs from American manufacturers. More than 70 percent of drug ingredients supplied to the U.S. are from oversea companies.
There is growing bipartisan agreement that we need to bring pharmaceutical production back home. But one enormous hurdle remains.
"We cannot outsource our independence," Trump said Monday. "We cannot be reliant on foreign nations."